U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H7NO4
Molecular Weight 133.1027
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASPARTIC ACID

SMILES

N[C@@H](CC(O)=O)C(O)=O

InChI

InChIKey=CKLJMWTZIZZHCS-REOHCLBHSA-N
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1

HIDE SMILES / InChI

Molecular Formula C4H7NO4
Molecular Weight 133.1027
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15703381 | https://www.ncbi.nlm.nih.gov/pubmed/3814227 | https://www.ncbi.nlm.nih.gov/pubmed/16061593

Disodium aspartate is used in organic biosynthesis.

CNS Activity

Curator's Comment: Aspartic acid is produced in the brain and acts as endogenous neurotransmitter.

Originator

Curator's Comment: Aspartic acid was first discovered in 1827 by Auguste-Arthur Plisson and Étienne Ossian Henry by hydrolysis of asparagine, which had been isolated from asparagus juice in 1806

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q7L266
Gene ID: 80150.0
Gene Symbol: ASRGL1
Target Organism: Homo sapiens (Human)
18.4 µM [EC50]
Target ID: P08236
Gene ID: 2990.0
Gene Symbol: GUSB
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
6 g 1 times / day multiple, oral
Highest studied dose
Dose: 6 g, 1 times / day
Route: oral
Route: multiple
Dose: 6 g, 1 times / day
Sources:
healthy, 22.4 ± 2.6 years
n = 10
Health Status: healthy
Age Group: 22.4 ± 2.6 years
Sex: M
Population Size: 10
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer







Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
no
Drug as victim
PubMed

PubMed

TitleDatePubMed
Ketanserin for the treatment of preeclampsia.
2001
Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats.
2001
The biosynthesis of coenzyme A in bacteria.
2001
The biosynthesis of nicotinamide adenine dinucleotides in bacteria.
2001
Metabolism of [1-(13)C)glucose and [2-(13)C]acetate in the hypoxic rat brain.
2001 Apr
Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family.
2001 Apr 13
Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan.
2001 Apr 13
Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver.
2001 Feb
Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons.
2001 Feb
Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.
2001 Feb
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.
2001 Feb
Design, X-ray crystallography, molecular modelling and thermal stability studies of mutant enzymes at site 172 of 3-isopropylmalate dehydrogenase from Thermus thermophilus.
2001 Feb
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
2001 Feb
Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
2001 Feb
Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats.
2001 Feb
Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.
2001 Feb
DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids.
2001 Feb 1
Evidence for glutamate receptor mediated transmission at mechanoreceptors in the skin.
2001 Feb 12
Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists.
2001 Feb 16
Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease.
2001 Feb 16
Evidence for microvesicular storage and release of glycine in rodent pinealocytes.
2001 Feb 16
Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules--in vitro cryopreservation studies.
2001 Jan
Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.
2001 Jan
Structure activity relationship of antiproliferative N-acyl-aspartic acid dimethyl ester. 2. Variation of the aspartyl moiety.
2001 Jan
Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression.
2001 Jan
Plasma ascorbate concentrations are not correlated with milk somatic cell count and metabolic profile in lactating and dry cows.
2001 Jan
Dietary cancer risk from conditional cancerogens (tumor promoters) in produce of livestock fed on species of spurge (Euphorbiaceae). IV. Toxicologic and pathophysiologic observations in lactating goats and their suckling kids fed on the irritant herbs Euphorbia nubica and Euphorbia helioscopia: an etiologic model for investigations on the putative risk of cancer by consumption of food p.
2001 Jan
Exercise improved accumulation of visceral fat and simultaneously impaired endothelium-dependent relaxation in old rats.
2001 Jan
Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats.
2001 Jan
Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity.
2001 Jan
The effect of amino acid-modifying reagents on chloroplast protein import and the formation of early import intermediates.
2001 Jan
Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis.
2001 Jan
Effects of aflatoxin and carotenoids on growth performance and immune response in mule ducklings.
2001 Jan
A comparison of the effect of nitroparacetamol and paracetamol on liver injury.
2001 Jan
Effect of early arterialization of the porcine liver allograft on reperfusion injury, hepatocellular injury, and endothelial cell dysfunction.
2001 Jan
Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study.
2001 Jan
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse.
2001 Jan
Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Technical note.
2001 Jan
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome.
2001 Jan
Studies on the effects of lactate transport inhibition, pyruvate, glucose and glutamine on amino acid, lactate and glucose release from the ischemic rat cerebral cortex.
2001 Jan
Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes.
2001 Jan
Strain is more important than electrostatic interaction in controlling the pKa of the catalytic group in aspartate aminotransferase.
2001 Jan 16
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
2001 Jan 5
Positive and negative strands of HCV-RNA in sera and peripheral blood mononuclear cells of chronically hemodialyzed patients.
2001 Jan-Feb
Characterization, amino acid sequence and evolution of edema-inducing, basic phospholipase A2 from Trimeresurus flavoviridis venom.
2001 Jul
The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys.
2001 Jul
Metabolic changes after cardiac surgery.
2001 Mar
Association between serum concentrations of hexachlorobenzene and polychlorobiphenyls with thyroid hormone and liver enzymes in a sample of the general population.
2001 Mar
In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis.
2001 Mar 1
Pathobiochemical mechanisms involved in the control of the disease caused by Trypanosoma congolense in African grey duiker (Sylvicapra grimmia).
2001 Mar 5
Patents

Sample Use Guides

Aspartic acid is a nutrient component found in animal and vegetable sources. In clinical trials to alleviate opioid abstinence it was administered orally.
Route of Administration: Oral
Activation of recombinant NMDA receptors was measured using two-electrode voltage clamp. Current and voltage electrodes were made from thin-walled borosilicate glass using a PP-830 electrode puller and when filled with 3 M KCl, possessed resistances of between 0.5 and 1.5 MΩ. Oocytes were voltage-clamped at potentials of -40 mV. Aspartate was able to activate wild type NR1/NR2A NMDA receptors with EC50 of 18.4 uM.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:00:57 UTC 2023
Edited
by admin
on Fri Dec 15 15:00:57 UTC 2023
Record UNII
30KYC7MIAI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASPARTIC ACID
EP   HSDB   II   INCI   INN   MART.   MI   USAN   USP   VANDF   WHO-DD  
USAN   INN   INCI  
Official Name English
L-ASPARTIC ACID
FCC   FHFI  
Systematic Name English
ASPARTIC ACID [USP MONOGRAPH]
Common Name English
ASPARTIC ACID [MI]
Common Name English
ASPARTIC ACID [HSDB]
Common Name English
ALANINE IMPURITY A [EP IMPURITY]
Common Name English
L-ASPARTIC ACID [FCC]
Common Name English
ASPARTIC ACID [II]
Common Name English
L-ASPARTIC ACID [FHFI]
Common Name English
ASPARTIC ACID [MART.]
Common Name English
DEAMIDATED ASPARAGINE
Common Name English
ASPARTIC ACID [USAN]
Common Name English
Aspartic acid [WHO-DD]
Common Name English
FEMA NO. 3656
Code English
ASPARTIC ACID [VANDF]
Common Name English
ASPARTIC ACID [USP-RS]
Common Name English
LYSINE ACETATE IMPURITY A [EP IMPURITY]
Common Name English
L-ASPARTIC ACID [JAN]
Common Name English
aspartic acid [INN]
Common Name English
ASPARTIC ACID [EP MONOGRAPH]
Common Name English
ASPARTIC ACID, L-
Common Name English
(2S)-2-AMINOBUTANEDIOIC ACID
Systematic Name English
ASPARTIC ACID [INCI]
Common Name English
ASPARTIC ACID [EP IMPURITY]
Common Name English
ASPARTATE
Systematic Name English
Classification Tree Code System Code
LOINC 1911-7
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
NCI_THESAURUS C29596
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47576-4
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 1914-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 30061-6
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 15143-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
JECFA EVALUATION L-ASPARTIC ACID
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
NCI_THESAURUS C68442
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 27256-7
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 22723-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 56640-6
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 25865-7
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 15135-7
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 22691-0
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47574-9
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 1913-3
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 13711-7
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47573-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 22677-9
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47578-0
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 20639-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 26680-9
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 55913-8
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
CFR 21 CFR 172.320
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 25864-0
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 22655-5
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 25327-8
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 13389-2
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 1912-5
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
DSLD 2408 (Number of products:573)
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 32232-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47577-2
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 47575-6
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 1915-8
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 44302-8
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
DSLD 181 (Number of products:10)
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 32231-3
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
LOINC 16411-1
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
Code System Code Type Description
CHEBI
22660
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
MERCK INDEX
m2100
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY Merck Index
MESH
D001224
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
INN
1570
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
ChEMBL
CHEMBL274323
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
EVMPD
SUB11721MIG
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
FDA UNII
30KYC7MIAI
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
DAILYMED
30KYC7MIAI
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
JECFA MONOGRAPH
1419
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
EVMPD
SUB32314
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
CHEBI
29995
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
RXCUI
42543
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
ALTERNATIVE
WIKIPEDIA
ASPARTIC ACID
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
HSDB
1430
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
NCI_THESAURUS
C29608
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
EPA CompTox
DTXSID7022621
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
SMS_ID
100000091847
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
CHEBI
72314
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
DRUG CENTRAL
1550
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-291-6
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
CHEBI
17053
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
RS_ITEM_NUM
1043819
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
CHEBI
29958
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
PUBCHEM
5960
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
DRUG BANK
DB00128
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
CAS
56-84-8
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
RXCUI
1169
Created by admin on Fri Dec 15 15:00:57 UTC 2023 , Edited by admin on Fri Dec 15 15:00:57 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> METABOLITE
MAJOR
PLASMA
Related Record Type Details
IMPURITY -> PARENT
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (TLC)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (TLC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY